登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603815 证券简称：交建股份 公告编号：2025-022 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 根据上海证券交易所《上海证券交易所上市公司自律监管指引第1号——规范运作》和《上海证券交易 所上市公司自律监管指南第1号——公告格式》的规定，将安徽省交通建设股份有限公司（以下简称本 公司或公司）2024年度募集资金存放与使用情况报告如下： 一、 募集资金基本情况 经中国证券监督管理委员会证监许可[2021]18号文核准，公司于2021年6月向社会非公开发行人民币普 通股（A股）119,924,235股，每股发行价为7.26元，募集资金总额为人民币87,064.99万元，根据有关规 定扣除发行费用1,143.70万元后，实际募集资金金额为85,921.30万元。该募集资金已于2021年6月到账。 上述资金到账情况业经容诚会计师事务所（特殊普通合伙）容诚验字[2021]230Z0133号《验资报告》验 证。公司对募集资金采取了专户存储管理。 2024年度，本公司 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002551 证券简称：尚荣医疗 公告编号：2025-023 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 根据中国证监会发布的《上市公司监管指引第2号——上市公司募集资金管理和使用的监管要求》和深 圳证券交易所颁布的《深圳证券交易所股票上市规则》、《深圳证券交易所上市公司自律监管指引第1 号——主板上市公司规范运作》、《深圳证券交易所上市公司自律监管指南第2号——公告格式》等有 关规定，深圳市尚荣医疗股份有限公司（以下简称"公司"或"本公司"），深圳市尚荣医疗股份有限公司 （以下简称"公司"或"本公司"）董事会编制了截至2024年度募集资金存放与实际使用情况的专项报告。 一、募集资金基本情况 根据相关制度，本公司于2019年2月28日与北京银行股份有限公司深圳分行、兴业银行股份有限公司深 圳龙岗支行、中国民生银行股份有限公司深圳上步支行、平安银行股份有限公司深圳分行、中国工商银 行股份有限公司深圳东门支行及保荐机构东兴证券股份有限公司签署《募集资金三方监管协议》。对募 集资金的使用实行严格的审批手 ...

Fundraising Overview - The company raised a total of RMB 754.56 million through the issuance of 32 million shares at a price of RMB 23.58 per share, with a net amount of RMB 685.86 million after deducting underwriting fees [1] - As of December 31, 2023, the cumulative amount directly invested in fundraising projects was RMB 285.64 million, with an unutilized amount of RMB 438.47 million [2] Fund Utilization in 2024 - In 2024, the company utilized RMB 284.99 million of the raised funds, including expenditures for various projects such as RMB 0.79 million for the automated production base and RMB 18.01 million for acquiring equity in Hongtong Technology [3] - By December 31, 2024, the total amount directly invested in fundraising projects reached RMB 570.63 million, with an unutilized balance of RMB 158.55 million [3][4] Fund Management and Storage - The company established a dedicated account for the management and storage of raised funds, ensuring compliance with relevant regulations and protecting investor interests [4][5] - As of December 31, 2024, the total balance in the fundraising special account was RMB 77.15 million, which included cash management products [6] Changes in Fund Usage - The company approved changes in the use of funds, reallocating RMB 18.01 million from the automated production base project to acquire a 60% stake in Hongtong Technology [8][19] - Additionally, RMB 15.49 million was reallocated to increase capital for Hongtong Technology's factory capacity enhancement in Thailand [19] Idle Fund Management - The company decided to use up to RMB 300 million of idle funds for cash management, investing in low-risk, liquid financial products [6][14] - As of December 31, 2024, the cash management products balance was RMB 81.40 million, which included RMB 34.40 million in seven-day notice deposits and RMB 47 million in large time deposits [6][14] Fund Usage Reporting - The company confirmed that all disclosed information regarding the use of raised funds is timely, accurate, and complete, complying with relevant laws and regulations [24] - The special report on fundraising was approved by the board on April 28, 2025 [25]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002099 证券简称：海翔药业 公告编号：2025-012 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 根据中国证券监督管理委员会《上市公司监管指引第2号——上市公司募集资金管理和使用的监管要求 （2022年修订）》（证监会公告〔2022〕15号）和深圳证券交易所印发的《深圳证券交易所上市公司自 律监管指引第1号——主板上市公司规范运作（2023年12月修订）》（深证上〔2023〕1145号）的规 定，将本公司募集资金2024年度存放与使用情况专项说明如下。 一、募集资金基本情况 （一）实际募集资金金额和资金到账时间 经中国证券监督管理委员会证监许可〔2016〕765号文核准，并经深圳证券交易所同意，本公司由主承 销商国泰君安证券股份有限公司采用非公开发行方式，向特定对象非公开发行人民币普通股（A股）股 票9,989.0023万股，发行价为每股人民币10.28元，共计募集资金102,686.94万元，坐扣承销和保荐费用 1,000万元后的募集资金为101,686.94万元，已由主承销商国泰君安证 ...

Financial Overview - The overall performance of the company in Q1 2025 showed a significant decline, with total revenue at 99.1861 million yuan, a decrease of 0.96% year-on-year; net profit attributable to shareholders was -16.5332 million yuan, down 336.39% year-on-year; and net profit excluding non-recurring items was -17.9109 million yuan, a decrease of 247.04% year-on-year [2]. Profitability Analysis - The company's gross margin was 61.23%, a decrease of 21.37 percentage points year-on-year; the net margin was -18.36%, a substantial decline of 587.53 percentage points, indicating significant challenges in cost control and profitability [3]. Costs and Expenses - Total selling, administrative, and financial expenses amounted to 53.0594 million yuan, accounting for 53.49% of total revenue, an increase of 6.7 percentage points compared to the same period last year, reflecting increased pressure on operational costs [4]. Assets and Cash Flow - As of the end of the reporting period, the company's cash and cash equivalents were 273 million yuan, a decrease of 45.02% year-on-year; accounts receivable were 167 million yuan, an increase of 22.12% year-on-year; operating cash flow per share was -0.2 yuan, a decrease of 62.0% year-on-year, indicating risks in fund management and cash flow [5]. Other Key Indicators - The net asset value per share was 3.96 yuan, a decrease of 2.49% year-on-year; earnings per share were -0.04 yuan, down 335.05% year-on-year; interest-bearing debt was 1.0636 million yuan, a decrease of 36.00% year-on-year [6]. Summary - Overall, the company's performance in Q1 2025 was weak, particularly in terms of profitability and cash flow. The company needs to closely monitor accounts receivable collection and implement effective measures to improve cash flow for sustainable future development [7].

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：001287 证券简称：中电港 公告编号：2025-010 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 根据《上市公司监管指引第2号——上市公司募集资金管理和使用的监管要求（2022年修订）》《深圳 证券交易所上市公司自律监管指引第1号——主板上市公司规范运作（2023年12月修订）》等相关规 定，深圳中电港技术股份有限公司（以下简称"公司"）2024年度募集资金存放与使用的具体情况说明如 下： 一、募集资金的基本情况 （一）实际募集资金金额、资金到账时间 根据中国证券监督管理委员会2023年3月16日发布的《关于同意深圳中电港技术股份有限公司首次公开 发行股票注册的批复》（证监许可〔2023〕584号），公司首次向社会公开发行人民币普通股 18,997.5024万股，发行价格11.88元/股，募集资金总额225,690.33万元，扣除相关发行费用后实际募集资 金净额213,331.22万元。募集资金已于2023年4月3日划至公司指定账户，经信永中和会计师事务所（特 殊普通合伙）审验并出具《关于深 ...

同时，公司交易性金融资产增长43.98%，达到8,016万元，表明公司在保持合理运营资金的基础上，积 极通过购买银行理财产品提升资金使用效率。 张小泉2025年第一季度交出了一份亮眼的财务报表，净利润和扣非净利润分别同比增长69.49%和 85.47%，远超收入5.65%的增速。 值得关注的是，尽管利润表现亮眼，但公司经营活动产生的现金流量净额为-1393万元，同比下降 1418.08%。这一大幅下滑主要源于本期到期兑付银行承兑汇票增加，对公司短期流动性形成一定压 力。 4月28日晚间，张小泉发布一季度财报，以下是财报要点： 业务结构分析：电商渠道投入加码 从资产负债表变动看，公司预付款项达953万元，较上年末增长58.18%，主要是电商平台流量充值增 加，显示公司正加大线上渠道拓展力度。 值得警惕的是，公司存货减值准备计提较去年同期增加148.33%，反映出公司面临部分产品滞销和瑕疵 品增加的情况，可能与市场竞争加剧或产品结构调整有关。 现金流转负的隐忧 从利润表来看，公司毛利率保持相对稳定，销售费用率和管理费用率变化不大，但财务费用同比增长 46.89%，主要由于利息收入下降所致。此外，其他收益同比增长4 ...

Core Points - The People's Bank of China and the State Administration of Foreign Exchange have expanded the pilot program for multinational companies' integrated currency pool business to include Hunan and 15 other provinces [1][2] - The pilot program allows multinational companies to determine the concentration ratio of foreign debt and overseas loans based on macro-prudential principles, while maintaining some financial arrangement flexibility for individual member enterprises [1] - The program facilitates the management of global member enterprise funds by allowing domestic main accounts to handle cross-border currency collection and payment for overseas member enterprises [1] - The pilot program aims to improve fund management efficiency, reduce financial costs, and enhance risk management capabilities for enterprises [1] Company and Industry Summary - Two companies, Zoomlion Heavy Industry Science and Technology Co., Ltd. and Hunan Zhongwei New Energy Technology Co., Ltd., have been selected as pilot enterprises and have successfully completed the business filing [2] - The pilot companies have established a global fund pool covering 25 countries and regions, including 72 domestic and foreign member enterprises [2] - Feedback from the pilot enterprises indicates that the policy has provided more convenience for Hunan enterprises in their global operations and expansion [2]

Core Viewpoint - The company, Hunan Hualian Ceramics Co., Ltd., has released its first quarter report for 2025, ensuring the accuracy and completeness of the information disclosed, and confirming that the report has not been audited [1][2][7]. Financial Data - The company has confirmed that there are no adjustments or restatements required for previous accounting data [3]. - There are no non-recurring profit and loss items applicable for the reporting period [3]. - The company has not defined any items listed in the public offering securities disclosure as recurring profit and loss [3]. Shareholder Information - The report includes details on the total number of ordinary shareholders and the top ten shareholders, but no changes were reported regarding the lending of shares by major shareholders [5]. Board Meeting - The fifth board meeting of the company was held on April 25, 2025, with all nine directors present, and the meeting complied with legal and statutory requirements [9]. - The board approved the first quarter report for 2025 with unanimous support [10]. - The board also approved the establishment of a special account for fundraising and the signing of a four-party supervision agreement related to the funds [11]. Supervisory Meeting - The fifth supervisory meeting was also held on April 25, 2025, with all three supervisors present, and the meeting adhered to legal and statutory requirements [15]. - The supervisory board approved the first quarter report for 2025 with unanimous support [16]. - Similar to the board, the supervisory board approved the establishment of a special account for fundraising and the signing of a four-party supervision agreement [15].

登录新浪财经APP 搜索【信披】查看更多考评等级 具体事项详见公司刊登在《证券时报》《上海证券报》《中国证券报》《证券日报》和巨潮资讯网 （www.cninfo.com.cn）上披露的《关于会计师事务所2024年度审计费用的公告》（公告编号：2025- 024）。 九、审议通过《公司2024年度内部控制自我评价报告》 公司现有内部控制不存在重大缺陷。公司已按照企业内部控制规范体系建立并完善了一系列业务和内部 管理制度，相关制度得到有效地执行。 经审计部审慎调查，公司现有的内部控制制度符合我国有关法规和证券监管部门要求，符合当前公司生 产经营实际情况需要，相关制度得到有效地执行。 表决结果：同意票9票，反对票0票，弃权票0票。 《公司2024年度内部控制自我评价报告》详细内容请见巨潮资讯网（www.cninfo.com.cn）。 和信会计师事务所（特殊普通合伙）为公司出具了和信审字（2025）第000609号《内部控制审计报告》 详细内容请见巨潮资讯网（www.cninfo.com.cn）。 十、审议通过《公司2024年度募集资金存放与使用情况的专项报告》 已按《上市公司监管指引第2号一一上市公司募集资金管理和 ...